Searched for
MODERNA VACCINE IMPORT
Moderna Covid vaccine highly effective 5 months after second dose: Study"This research provides reassuring evidence of the high effectiveness of the Moderna COVID-19 vaccine in preventing infection, hospitalisat...- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- India offered 7.5 million doses of Moderna vaccine; no consensus on indemnity clause: SourcesAccording to the sources, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent ...
- Covid-19 vaccine: Moderna offered legal indemnity, but with ridersThe proposal, which has been further sent to Moderna, will be taken up by its board of directors and once approved, will allow immediate im...
- Working actively with Moderna to see how its Covid vaccine can be made available in India: GovtResponding to a question at a press briefing, NITI Aayog member (Health) Dr V K Paul said, "Moderna vaccine is under emergency use authoris...
- ‘India likely to grant indemnity to Moderna, soon’The shots of the Moderna vaccine, donated by the US government, will reach India once the issue of indemnity is sorted out. This could happ...
- India’s wait for Moderna vaccine could get longerThe US vaccine makers, including Pfizer, have been insisting that the Indian government should indemnify them against lawsuits in case of a...
- Moderna vaccine to be available at select hospitals by Mid-JulyLast week, Indian’s drug regulator granted permission to Cipla to import donated doses of Moderna from the US. The vax doses, which are bei...
- India's drug regulator okays Cipla's imports of Moderna COVID-19 vaccineCipla will import vaccines that have been donated by the US company to India. "This will not be for a commercial supply. Cipla is facilitat...
- Supporting Moderna for Covid vax to be donated to India: CiplaModerna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik V.
- Cipla gets DCGI nod to import Moderna's COVID-19 vaccine for restricted emergency use in IndiaModerna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.
- Moderna's COVID-19 vaccine may soon get regulatory approval in IndiaModerna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COV...
- Close to commit over $1-bn to Moderna for COVID-19 booster vaccine; Provide price capping waiver, indemnity: Cipla to GovtCommending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against CO...
- Pfizer, Moderna refuse to sell COVID-19 vaccines to Delhi govt directly, says CM Kejriwal"We have spoken to Pfizer and Moderna for vaccines, and both the companies have refused to sell vaccines directly to us. They have said tha...
- Covax signs deal for 500 mn Moderna Covid vaccine dosesThe doses, to come on stream from October at the earliest, will broaden out the portfolio of vaccines in the Covax scheme, which has so far...
- WHO gives Emergency Use Authorisation to Moderna's COVID jabAccording to The Hill, the shot from Moderna joins shots from Pfizer-BioNTech, AstraZeneca-SK Bio, Serum Institute of India and Janssen on ...
- Pricing negotiations with Centre means new vaccine shots may take time to reach IndiaThe new regulatory requirement is that the first 100 patients to receive the jab will be observed for seven days for any serious adverse re...
- Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approvalModerna's vaccine is currently under review by Canada's drug regulator. The Pfizer/BioNTech vaccine received regulatory approval last week ...
- Explained: How will Canada's COVID-19 vaccination program work?With limited manufacturing capacity, six of the vaccines the country has ordered will have to be imported and the first are unlikely to arr...
- US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
Load More
